Home > Insider Trading > Filing (0001209191-18-064285)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887151	Capstone Therapeutics Corp.	CAPS	Pharmaceutical Preparations (2834)	860585310

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201333	S Neil Subin	3300 South Dixie Highway Suite 1-365 West Palm Beach FL 33405		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-12-21	206,000	$0.05	2,708,484	No	4	S	Indirect	By MBM - Trust A-4
Common Stock	Acquisiton	2018-12-21	103,000	$0.05	727,100	No	4	P	Indirect	By LIMFAM LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By MBM - Trust A-4
No	4	P	Indirect	By LIMFAM LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,914,484	Indirect	By LIM III - Trust A-4
Common Stock	641,218	Indirect	By Trust C - Lloyd I. Miller
Common Stock	90,344	Indirect	By Trust D - Lloyd I. Miller
Common Stock	472,792	Indirect	By Milfam II L.P.

Footnotes

The reported transaction involved a sale of a total of 206,000 shares of Capstone Therapeutics Corp. ("Capstone") common stock by MBM -Trust A-4, which were acquired by LIMFAM LLC and another private purchaser at a privately negotiated price equal to $0.052 per share. The reporting personmay be deemed to have voting and dispositive control over shares held by MBM - Trust A-4 and LIMFAM LLC.
The reporting person believes that the reported transaction constitutes a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Act pursuant to Rule 16a-13.
Except for possessing voting and dispositive power, the reporting person disclaims any other beneficial ownership of, and specifically any pecuniary interest in, the securities reported herein. This filing is not, and shall not be deemed, an admission (and the reporting person expressly disclaims) that the reporting person is, for purposes of Rule 16a-1(a)(2) under Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any equity securities covered by this filing.
The reporting person succeeded to the position of President and Manager of MILFAM LLC, which serves as manager, general partner, or investment advisor of a number of entities formerly managed or advised by the late Lloyd I. Miller, III. The reporting person also serves as trustee of a number of Miller family trusts.